HomeBUSINESS
BUSINESS

Vortioxetine Showed Positive Results in Japan PIII with MDD Patients: Takeda/Lundbeck
(Jun.12.2018)

Takeda Pharmaceutical and its Danish partner Lundbeck A/S announced on June 11 positive results from a Japan PIII trial of vortioxetine in adults with major depressive disorder (MDD) ...
(LOG IN FOR FULL STORY)

News Calendar